Enigmatig vs Lichen International
EGG and LICN side by side, both in management and public relations services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EGG and LICN compare
Enigmatig keeps more of each dollar of sales as profit, with a net margin of 12.6% compared with −2715% at Lichen International.
Enigmatig scores higher on the StockData Score (10 against 5 for Lichen International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EGG | LICN |
|---|---|---|
| Size and price | ||
| Share price | $5.90 | $0.040 |
| Change, 1 year | 44.6% | −98.9% |
| Beta (5Y) | −0.28 | – |
| Employees | 18 | 399 |
| StockData Score | ||
| Total score | 10 (better) | 5 |
| Valuation score | 0 | 0 |
| Growth score | 2 (better) | 0 |
| Performance score | 3 (better) | 0 |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 12.2% | – |
| Revenue growth, 5Y average | – | −51.7% |
| Net income growth (TTM) | −31.8% | – |
| EPS growth (TTM) | −33.3% | – |
| Profitability | ||
| Gross margin | 68.8% | 1129% (better) |
| Operating margin | 12.1% (better) | −2234% |
| Net margin | 12.6% (better) | −2715% |
| FCF margin | −44.1% (better) | −2206% |
| Return on equity | 7.1% (better) | −35.1% |
| Return on invested capital | 69.5% (better) | −34.4% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 6.94 (better) | 5.81 |
| Piotroski F-score | 5 (better) | 3 |
| Ownership | ||
| Held by insiders | – | 0.00% |
| Short interest, % of float | – | 0.62% |
Go deeper
- EGG stock overview
- EGG income statement
- EGG valuation and score
- LICN stock overview
- LICN income statement
- LICN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.